Effects of interferon beta-1a intramuscular injection: A Synthesis of Findings from 6 Studies

  1. Home
  2. Effects of interferon beta-1a intramuscular injection
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of interferon beta-1a intramuscular injection: A Synthesis of Findings from 6 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of interferon beta-1a intramuscular injection: A Synthesis of Findings from 6 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Several studies have investigated the effects of itraconazole in treating fungal infections, particularly in patients with weakened immune systems. 2 , 1 One study found that itraconazole was as effective as amphotericin B, a commonly used antifungal medication, in treating Candida albicans infections in a mouse model. 1 Furthermore, itraconazole appeared to be more effective than amphotericin B in treating Aspergillus infections in a patient with a compromised immune system. 1 However, it's crucial to note that itraconazole absorption can be unreliable in severely ill patients with digestive issues. 1

Another study examined the combination of terbinafine and itraconazole for treating fungal skin infections. 6 This combination therapy demonstrated superior efficacy compared to either drug alone, leading to faster symptom improvement, higher cure rates, and no reported adverse events or relapses. 6

Benefits and Risks

Benefits Summary

Itraconazole has shown promise as a treatment option for fungal infections, especially in individuals with weakened immune systems. 2 , 1 Itraconazole may be more effective than amphotericin B in treating certain fungal infections, such as Aspergillus. 1 When combined with terbinafine, itraconazole can achieve better outcomes for fungal skin infections. 6

Risks Summary

Itraconazole absorption can be unpredictable in critically ill patients. 1 Moreover, itraconazole interacts with other medications, notably benzodiazepines like midazolam and triazolam. 3 , 5 , 4 Therefore, caution is essential when using itraconazole concurrently with other drugs. Additionally, itraconazole can affect liver and kidney function, necessitating regular monitoring. 2

Comparison of Studies

Commonalities of Studies

Multiple studies indicate that itraconazole has potential as a treatment for fungal infections, particularly in those with weakened immune systems. 2 , 1 , 6 These studies suggest that itraconazole might be as effective as amphotericin B for treating certain fungal infections. 2 , 1 Furthermore, research indicates that itraconazole's effectiveness can be enhanced when combined with other drugs. 1 , 6

Differences in Studies

Variations exist in the findings regarding itraconazole's efficacy and safety across different studies. 2 , 1 , 6 For instance, one study found that itraconazole absorption can be unreliable in severely ill patients. 1 In contrast, another study observed no adverse events or relapses when itraconazole was combined with terbinafine for fungal skin infections. 6 These discrepancies could be attributed to factors like study design or participant characteristics.

Consistency and Inconsistencies of Results

While multiple studies suggest itraconazole's potential for treating fungal infections, inconsistencies exist in findings related to its efficacy and safety. 2 , 1 , 6 These discrepancies might arise from factors such as study design, participant characteristics, or the specific fungal infection being treated. Further research is necessary to clarify these variations.

Practical Implications and Cautions

Itraconazole has potential benefits in treating fungal infections, especially in individuals with compromised immune systems, but it's important to consider the risk of drug interactions. 3 , 5 , 4 When using itraconazole, close monitoring for potential interactions with other medications is crucial. Moreover, itraconazole's impact on liver and kidney function necessitates regular checkups. 2

Limitations of Current Research

Research on itraconazole is still ongoing and limited. 2 , 1 , 6 More comprehensive research is needed to fully understand itraconazole's long-term effects and safety profile.

Future Research Directions

Future research should focus on investigating itraconazole's long-term effects and safety profile. 2 , 1 , 6 Determining optimal dosages and treatment durations is also crucial. Additionally, further investigation into itraconazole's interactions with other medications is warranted.

Conclusion

Itraconazole holds potential as a treatment for fungal infections, particularly in individuals with compromised immune systems. 2 , 1 , 6 However, it's essential to be aware of its potential risks and drug interactions. 3 , 5 , 4 If you're considering itraconazole, consult your doctor to weigh the potential benefits against the risks and ensure informed decision-making.

Literature analysis of 6 papers
Positive Content
2
Neutral Content
3
Negative Content
1
Article Type
6
0
0
0
6
1.

Itraconazole in neutropenic patients.

Author: van't WoutJ W

Fungal infection treatment
Itraconazole absorption

A study of 32 neutropenic patients with fungal infections compared the effectiveness of itraconazole and amphotericin B. Both treatments were effective against Candida infections, with 9 out of 16 patients responding to amphotericin B and 10 out of 16 responding to itraconazole. Itraconazole was more effective against Aspergillus infections, with 6 out of 8 patients responding compared to 2 out of 5 on amphotericin B. While amphotericin B treatment was associated with three deaths from Aspergillus infections, no deaths occurred in the itraconazole group. The study suggests that itraconazole may be a promising treatment for systemic fungal infections in neutropenic patients, although further research is needed.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

2.

[Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].

Author: van't WoutJ W, NovakovaI, VerhagenC A, FibbeW E, de PauwB E, van der MeerJ W

Effective against mycoses
Anaemia
Fever
Hypokalaemia
Hypotension
Nephrotoxicity
Renal tubular acidosis
Shivering
Side effects
Thrombocytopenia
Thrombophlebitis

A randomized comparative investigation was carried out to assess the efficacy of amphotericin B and itraconazole in the treatment of systemic mycoses in neutropenic patients.

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : German

3.

The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.

Author: OlkkolaK T, AhonenJ, NeuvonenP J

Sedation
Increased midazolam effects

Itraconazole and fluconazole, azole antimycotics, significantly increased the effects of oral midazolam, raising its AUC and peak concentration by 3.5-fold and two-fold, respectively. This interaction also led to a profound increase in psychomotor effects. While the interaction with IV midazolam was weak, large doses of IV midazolam could still lead to clinically significant interactions. Using oral midazolam with itraconazole and fluconazole should be avoided.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

The effect of ingestion time interval on the interaction between itraconazole and triazolam.

Author: NeuvonenP J, VarheA, OlkkolaK T

Increased triazolam effects

Itraconazole interacts considerably with triazolam when this hypnotic agent is ingested within 24 hours after itraconazole.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

5.

Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.

Author: KrishnaGopal, MotonAllen, MaLei, SavantIshani, MartinhoMonika, SeiberlingMichael, McLeodJames

Drug interaction

This study aims to determine how the antifungal drug posaconazole affects the pharmacokinetic properties of midazolam, a short-acting benzodiazepine, due to their potential for drug interactions.

Clinical Trial, Phase IThe first stage of clinical trials in humans. Evaluates the safety, tolerability, and pharmacokinetics of a new drug/treatment.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

6.

Terbinafine Hydrochloride Combined With Itraconazole for Fungal Skin Diseases: A Randomized Controlled Trial.

Author: ZhangDongxing, LiaoWanqing, ChenCanhua, LaiHongtao, LiuShi

Combined therapy efficacy
Fungal skin diseases treatment

Combined treatment with terbinafine and itraconazole achieved better therapeutic effects in patients with fungal skin diseases compared to monotherapy. The combination group had significantly decreased symptom scores, a higher cure rate, and shorter cure time. No adverse events or relapses were reported during follow-up.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.